v3 Template
C

Calidi Biotherapeutics Inc.

Biotechnology / Healthcare San Diego, California ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$91.2M
Funding Rounds
14
Last Funding
2025-08-21

About Calidi Biotherapeutics Inc.

Calidi Biotherapeutics is a clinical-stage biotechnology company focused on developing a new generation of targeted immunotherapies for solid tumors. Their mission is to arm the immune system to kill cancer by using 'off-the-shelf' stem cells to deliver viral payloads that kill cancer cells locally and supercharge the immune system to fight metastatic disease. Their platforms help the immune system recognize and attack 'hot' tumors, aiming to redefine cancer treatment.

Products & Services

Targeted Immunotherapies:Innovative therapies designed to attack solid tumors and train the immune system to hunt down cancer cells throughout the body.
CLD-201:A targeted antitumor virotherapy for solid tumors, recently cleared by the FDA for an IND application.
Systemic Oncolytic Platform:Features CD55-enhanced expression and IL-15 superagonist payload, presented at the ASCO Annual Meeting.

Specialties

Targeted Immunotherapies Antitumor Virotherapies Oncology Solid Tumor Treatments Systemic Oncolytic Platforms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering
A: 6900000
MR: -
FA: 6.9 million
FAN: 6900000
D: 2025-08-21
FD: 2025-08-21
2 investors
2 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering
A: 6000000
MR: -
FA: $6 million
FAN: 6000000
D: 2025-08-20
FD: 2025-08-20
2 investors
3 RT: Warrant Exercise
T: -
FT: Warrant Exercise
A: 4600000
MR: -
FA: approximately $4.6 million
FAN: 4600000
D: 2025-07-09
FD: 2025-07-09
-
4 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement
A: 3900000
MR: -
FA: 3.9 million
FAN: 3900000
D: 2025-03-31
FD: 2025-03-31
1 investors
5 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement
A: 3900000
MR: -
FA: $3.9 million
FAN: 3900000
D: 2025-03-28
FD: 2025-03-28
1 investors
6 RT: Public Offering
T: -
FT: Public Offering
A: 4250000
MR: -
FA: approximately $4.25 million
FAN: 4250000
D: 2025-01-10
FD: 2025-01-10
-
7 RT: Public Offering
T: -
FT: Public Offering
A: 7500000
MR: -
FA: 7.5 million
FAN: 7500000
D: 2024-11-15
FD: 2024-11-15
-
8 RT: Public Offering
T: -
FT: Public Offering
A: 7500000
MR: -
FA: 7.5 million
FAN: 7500000
D: 2024-11-14
FD: 2024-11-14
-
9 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement
A: 2000000
MR: -
FA: Approximately $2 million
FAN: 2000000
D: 2024-10-23
FD: 2024-10-23
1 investors
10 RT: Warrant Exercise
T: -
FT: Warrant Exercise
A: 2100000
MR: -
FA: 2.1 million
FAN: 2100000
D: 2024-05-31
FD: 2024-05-31
-
11 RT: Public Offering
T: -
FT: Public Offering
A: 6100000
MR: -
FA: 6.1 million
FAN: 6100000
D: 2024-04-19
FD: 2024-04-19
1 investors
12 RT: Public Offering
T: -
FT: Public Offering
A: 6100000
MR: -
FA: approximately $6.1 million
FAN: 6100000
D: 2024-04-16
FD: 2024-04-16
-
13 RT: Grant
T: -
FT: Grant
A: 5300000
MR: -
FA: $5.3 million
FAN: 5300000
D: 2024-03-11
FD: 2024-03-11
1 investors
14 RT: Series B
T: -
FT: Series B
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2023-06-23
FD: 2023-06-23
2 investors
Underwritten Public Offering Latest
2025-08-21
$6.9M
2 investors (Pro only)
Underwritten Public Offering 2025-08-20
$6.0M
Warrant Exercise 2025-07-09
$4.6M

View 13 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Eric Poma

Chief Executive Officer and board director

A

Andrew Jackson

Financial Executive

A

Antonio F. Santidrian

Chief Scientific Officer

G

Guy Travis Clifton

Chief Medical Officer

B

Boris Minev

Physician-Scientist

W

Wendy Pizarro

Chief Legal Officer and Chief Diversity Officer

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Calidi Biotherapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~460 employees (est.)
Locations
San Diego, California

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro